Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 



